19.02.2013 14:50 Uhr, Quelle: Wallstreet online

Sobi and Savient Pharmaceuticals Announce Co-Promotion Agreement for Kineret® (anakinra) in the U.S.

CONTACT: Swedish Orphan Biovitrum (Sobi) ABAlan RaffenspergerChief Operating Officer+46 8 697 20 90 Savient Pharmaceuticals, Inc.              John P. HamillSenior Vice President and Chief Financial Officerinformation@savient.com …

Weiterlesen bei Wallstreet online

Digg del.icio.us Facebook email MySpace Technorati Twitter

JustMac.info © Thomas Lohner - Impressum - Datenschutz